Giants of Cancer CareĀ® Program Inductees

BREAST CANCER

Gabriel N. Hortobagyi, MD

The University of Texas MD Anderson Cancer Center

  • Developed and promoted the use of presurgical chemotherapy in patients with large tumors, reducing the tumors to 50% of their size prior to surgery and enabling subsequent surgical removal
  • Involved in the drug development of anthracyclines and taxanes in breast cancer therapy
  • Established the role of bisphosphonates in the management of bone metastases from breast cancer
  • Developed gene therapy approaches to breast cancer, and played a role in the initial development of gene expression profiling and its prognostic and predictive application in breast cancers
  • Past president of the American Society of Clinical Oncology
  • Chair of the Southwest Oncology Group since 2007
  • Recipient of numerous awards, including the 2012 William L. McGuire Award and Memorial Lecture, CTCR-AACR San Antonio Breast Cancer Symposium, and the 1997 Brinker International Award for Clinical Research
Back to 2015 Inductees

Home

)

SUPPORTED BY